Evidence map›Paper›PMID 28225026›Full record

ArticleScientific reports2017

Blood-based omic profiling supports female susceptibility to tobacco smoke-induced cardiovascular diseases.

Aristotelis Chatziioannou, Panagiotis Georgiadis, Dennie G Hebels, Irene Liampa, Ioannis Valavanis, Ingvar A Bergdahl, Anders Johansson, Domenico Palli, Marc Chadeau-Hyam, Alexandros P Siskos and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Creating and Validating a DNA Methylation-Based Proxy for Interleukin-6.The journals of gerontology. Series A, Biological sciences and medical sciences · 2021
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 8 countries.

Aristotelis ChatziioannouNational Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, 48 Vas. Constantinou Ave., Athens 11635, Greece.
Panagiotis GeorgiadisNational Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, 48 Vas. Constantinou Ave., Athens 11635, Greece.
Dennie G HebelsMaastricht University, Minderbroedersberg 4-6, 6211 LK, Maastricht, Netherlands.
Irene LiampaNational Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, 48 Vas. Constantinou Ave., Athens 11635, Greece.
Ioannis ValavanisNational Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, 48 Vas. Constantinou Ave., Athens 11635, Greece.
Ingvar A BergdahlDepartment of Biobank Research, and Occupational and Environmental Medicine, Department of Public Health and Clinical Medicine, Umeå University, Sweden.
Anders JohanssonNutrition Research, Department of Public Health and Clinical Medicine, Umeå University, Sweden.
Domenico PalliThe Institute for Cancer Research and Prevention, Italy.
Marc Chadeau-HyamImperial College London, MRC-HPA Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, W2 1PG, UK.
Alexandros P SiskosDepartment of Surgery and Cancer, Faculty of Medicine, Imperial College London, South Kensington, London SW7 2AZ, UK.
Hector KeunDepartment of Surgery and Cancer, Faculty of Medicine, Imperial College London, South Kensington, London SW7 2AZ, UK.
Maria BotsivaliNational Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, 48 Vas. Constantinou Ave., Athens 11635, Greece.
Theo M C M de KokMaastricht University, Minderbroedersberg 4-6, 6211 LK, Maastricht, Netherlands.
Almudena Espín PérezMaastricht University, Minderbroedersberg 4-6, 6211 LK, Maastricht, Netherlands.
Jos C S KleinjansMaastricht University, Minderbroedersberg 4-6, 6211 LK, Maastricht, Netherlands.
Paolo VineisImperial College London, MRC-HPA Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, W2 1PG, UK.
Soterios A KyrtopoulosNational Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, 48 Vas. Constantinou Ave., Athens 11635, Greece.
EnviroGenomarkers project consortium
Maastricht University · NLNational Taiwan University · TWImperial College London · GBNational Hellenic Research Foundation · GRUmeå University · SEFinnish Institute for Health and Welfare · FIUniversity of Leeds · GBIstituto Superiore di Sanità · ITUtrecht University · NLLund University · SEUniversity of Crete · GRCenter for Research in Environmental Epidemiology · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently reported that differential gene expression and DNA methylation profiles in blood leukocytes of apparently healthy smokers predicts with remarkable efficiency diseases and conditions known to be causally associated with smoking, suggesting that blood-based omic profiling of human populations may be useful for linking environmental exposures to potential health effects. Here we report on the sex-specific effects of tobacco smoking on transcriptomic and epigenetic features derived from genome-wide profiling in white blood cells, identifying 26 expression probes and 92 CpG sites, almost all of which are affected only in female smokers. Strikingly, these features relate to numerous genes with a key role in the pathogenesis of cardiovascular disease, especially thrombin signaling, including the thrombin receptors on platelets F2R (coagulation factor II (thrombin) receptor; PAR1) and GP5 (glycoprotein 5), as well as HMOX1 (haem oxygenase 1) and BCL2L1 (BCL2-like 1) which are involved in protection against oxidative stress and apoptosis, respectively. These results are in concordance with epidemiological evidence of higher female susceptibility to tobacco-induced cardiovascular disease and underline the potential of blood-based omic profiling in hazard and risk assessment.

Indexed as

AdultAgedCardiovascular DiseasesCpG IslandsDNA MethylationEpigenesis, GeneticEpigenomicsFemaleGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHumansMaleMiddle AgedSex FactorsTobacco Smoke PollutionTobacco Smoke Pollution

Identifiers

PMID28225026
PMCPMC5320491
OpenAlexW2590196513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.